NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern
Authors
Keywords
-
Journal
BLOOD
Volume 118, Issue 13, Pages 3645-3656
Publisher
American Society of Hematology
Online
2011-08-03
DOI
10.1182/blood-2011-04-346643
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value
- (2010) S. Abbas et al. BLOOD
- Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique
- (2010) Brian V. Balgobind et al. EUROPEAN JOURNAL OF CANCER
- Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia
- (2010) B. V. Balgobind et al. HAEMATOLOGICA
- Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia
- (2010) I. H. I. M. Hollink et al. HAEMATOLOGICA
- Inhibition of CRM1-mediated Nuclear Export of Transcription Factors by Leukemogenic NUP98 Fusion Proteins
- (2010) Akiko Takeda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High frequencies of simultaneous FLT3-ITD, WT1 and KIT mutations in hematological malignancies with NUP98-fusion genes
- (2010) T Taketani et al. LEUKEMIA
- The vent-like homeobox gene VENTX promotes human myeloid differentiation and is highly expressed in acute myeloid leukemia
- (2010) V. P. S. Rawat et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia
- (2009) I. H. I. M. Hollink et al. BLOOD
- Histone acetyl transferases as emerging drug targets
- (2009) Frank J. Dekker et al. DRUG DISCOVERY TODAY
- Mammalian Ste20-like protein kinase 3 induces a caspase-independent apoptotic pathway
- (2009) Chia-Ying Lin et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Favorable Prognostic Impact ofNPM1Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study
- (2009) Heiko Becker et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients
- (2009) W-C Chou et al. LEUKEMIA
- Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis
- (2009) L Bullinger et al. LEUKEMIA
- Dissection of the Transformation of Primary Human Hematopoietic Cells by the Oncogene NUP98-HOXA9
- (2009) Enas R. Yassin et al. PLoS One
- Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia
- (2009) I. Radtke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acquired copy number alterations in adult acute myeloid leukemia genomes
- (2009) M. J. Walter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SNPExpress: integrated visualization of genome-wide genotypes, copy numbers and gene expression levels
- (2008) Mathijs A Sanders et al. BMC GENOMICS
- Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML
- (2008) I H I M Hollink et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More